Evidence map›Paper›PMID 39569483›Full record

ReviewHealth promotion international2024

Can health impact assessment help tackle commercial determinants of health and support a wellbeing economy?

Margaret J Douglas, Catherine Foster, Rosalind McDermott, Lukas Bunse, Timo Clemens, Jodie Walker, Liz Green

Abstract readReview
In one paragraph

Review in Health promotion international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Margaret J DouglasPublic Health Scotland, Economy and Poverty Programme, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK.ORCID 0000-0003-1560-5451
Catherine FosterPublic Health Scotland, Economy and Poverty Programme, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK.ORCID 0000-0003-1609-9458
Rosalind McDermottPublic Health Department, Southwark Council, 160 Tooley Street, London SE1 2QH, UK.ORCID 0009-0004-6636-658X
Lukas BunseWEAll Scotland, Princes House, 51 West Campbell Street, Glasgow G2 6SE, UK.ORCID 0000-0002-8119-0541
Timo ClemensDepartment of International Health, Care and Public Health Research Institute-CAPHRI, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.ORCID 0000-0002-6820-2202
Jodie WalkerPublic Health Scotland, Economy and Poverty Programme, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK.ORCID 0009-0002-1795-1825
Liz GreenPolicy and International Health Directorate, WHO Collaborating Centre on 'Investment in Health and Well-being', Public Health Wales, Number 2 Capital Quarter, Tyndall Street, Cardiff CF10 4BZ, UK.ORCID 0000-0001-9218-3526

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Commercial activity has positive and negative effects on health. Adverse commercial impacts on health are underpinned by corporate power and economic models and policy that prioritize economic growth, rather than a wellbeing economy that prioritizes health, equity and sustainability. Health in all policies (HiAP) aims to ensure that all policies promote health and health equity, using processes including health impact assessment (HIA). We aimed to explore the potential for HiAP and HIA to help address commercial determinants of health and promote a wellbeing economy. We completed a scoping review to identify how HiAP approaches, including HIA, could address commercial determinants, including challenges and implications for practice. This found synergy between the concepts of wellbeing economy and HiAP. However, corporate interests have sometimes co-opted HiAP to influence policy. We found some examples of HIAs of transnational corporations and international trade and investment agreements. We reviewed HIA frameworks for guidance to practitioners on managing corporate influence. This identified little guidance on identifying and managing corporate and other conflicts of interest or managing power differentials between stakeholders. We also mapped wellbeing economy outcomes against health determinants considered in selected HIA frameworks. This found that HIA frameworks with a comprehensive checklist of health determinants prompt consideration of most wellbeing economy outcomes. HIA could support the transition to a wellbeing economy if applied routinely to economic policies, but ideational change is also needed. HIA frameworks should provide guidance on corporate conflicts of interest and power differentials.

Indexed as

CommerceHealth Impact AssessmentHealth PolicyHealth EquityHumansSocial Determinants of Healthcommercial determinants of healthhealth impact assessmenthealth in all policieshealthy public policysocial determinants of healthwellbeing economy

Identifiers

PMID39569483
PMCPMC11579598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.